PR Newswire Asia's news > Medical/Pharmaceuticals

 < Previous page   |   Title only   |   Print    Next page > 
     
Tinnitus Quest Builds Momentum with Oxford Research Study, New Funding Call, and Second Tinnitus Hackathon
OXFORD, England , June 18, 2026 /PRNewswire/ -- Tinnitus Quest , an international patient-driven nonprofit dedicated to accelerating research into treatments to silence tinnitus, today announced the ...
2026-06-18T    Health Care/Hospital   Medical/Pharmaceuticals 
Insilico Completes First-in-Human Dosing in Phase I Clinical Study of AI-Driven NLRP3 Inhibitor ISM8969, Achieving First Clinical Milestone in Collaboration with Hygtia Therapeutics
CAMBRIDGE, Mass. and HONG KONG , June 17, 2026 /PRNewswire/ -- Insilico Medicine ("Insilico", HKEX: 3696), a clinical-stage biotechnology company powered by generative artificial intelligence ...
2026-06-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
FiberSense Continuous Glucose Monitoring (CGM) System obtains CE mark as commercial launch preparations begin
Major regulatory milestone paves the way for commercialization and marks first step toward broader CxM biomarker sensing strategy ...
2026-06-17T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Gesynta Pharma Randomizes 50% of Patients in Phase 2 Endometriosis Trial of Vipoglanstat
STOCKHOLM , June 17, 2026 /PRNewswire/ -- Gesynta Pharma AB, a Swedish clinical stage pharmaceutical company focusing on chronic inflammatory diseases, today announced that 50% of the target of 190 ...
2026-06-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Ligufalimab (CD47)-Based Combination Achieves Deep Responses and Survival Benefit in Frontline AML: Phase II Results Presented in Oral Session at EHA 2026
HONG KONG , June 17, 2026 /PRNewswire/ -- Akeso, Inc. (9926.HK) ("Akeso" or the "Company") today announced that compelling results from its randomized, double-blind, placebo-controlled ...
2026-06-17T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
RRSĀ® HA Long Lasting awarded Best Injectable in Skin Revitalization at AMWC 2026, reinforcing Skin Tech Pharma Group's leadership in the Skin Builder category
BARCELONA, Spain , June 17, 2026 /PRNewswire/ -- Skin Tech Pharma Group proudly announces that its flagship injectable, RRS® HA LONG LASTING, has been recognized as Best Injectable in the Skin Revitalization ...
2026-06-17T    Cosmetics & Personal Care   Health Care/Hospital   Medical/Pharmaceuticals 
Ruixiang Silicone Releases Platinum-Cured Medical Silicone Tubing for Cardiac, Infusion, and Hemodialysis Device Manufacturers
USP Class VI, ISO 10993 biocompatibility evaluation, and ISO 13485:2016 quality system certification, manufactured at an FDA-registered facility ...
2026-06-16T    Biotechnology   Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
Datasea Intelligent Technology Ltd. Announces CEO's Intention to Purchase Up to US$1.0 Million of the Company's Class A Ordinary Shares
BEIJING , June 16, 2026 /PRNewswire/ -- Datasea Intelligent Technology Ltd. (Nasdaq: DTSS) ("Datasea" or the "Company"), a technology company focused on acoustic high-tech and AI ...
2026-06-16T    Banking/Financial Service   Computer/Electronics   Medical/Pharmaceuticals 
2026 Tang Prize in Biopharmaceutical Science Awarded to Three Pioneers of Cellular Immunotherapy
Revolutionizing Treatments for Blood Cancers and Solid Tumors ...
2026-06-16T    Biotechnology   Health Care/Hospital   Medical/Pharmaceuticals 
Crescom Launches Global PoC of Pediatric Musculoskeletal AI with Mass General Brigham
Mass General Brigham Department of Radiology Begins Clinical Validation and Utility of Three MediAI Pediatric Solutions ...
2026-06-16T    Health Care/Hospital   Medical Equipment   Medical/Pharmaceuticals 
 < Previous page    Next page >

 

88iv | Home |  Login
Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer
Copyright (C) 2026
Suntek Computer Systems Limited.
All rights reserved